T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$3.11B |
| 2 |
Meta Platforms (Facebook)
META
|
+$2.59B |
| 3 |
EQT Corp
EQT
|
+$1.31B |
| 4 |
Colgate-Palmolive
CL
|
+$1.08B |
| 5 |
Adobe
ADBE
|
+$1.06B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.92B |
| 2 |
UnitedHealth
UNH
|
+$1.78B |
| 3 |
Advanced Micro Devices
AMD
|
+$1.55B |
| 4 |
Ross Stores
ROST
|
+$1.54B |
| 5 |
ASML
ASML
|
+$1.49B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.61% |
| 2 | Healthcare | 16.91% |
| 3 | Consumer Discretionary | 11.05% |
| 4 | Financials | 10.6% |
| 5 | Communication Services | 9.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
801
Natera
NTRA
$44.8B
| $35.3M | ﹤0.01% |
725,879
+55,795
| +8% | +$2.85M |
|
802
Flywire
FLYW
$2.22B
| $35.3M | ﹤0.01% |
1,137,370
+92,477
| +9% | +$2.77M |
|
803
Addus HomeCare
ADUS
$2.2B
| $35.2M | ﹤0.01% |
379,571
+250
| +0.1% | +$23.9K |
|
|
SWTX
804
DELISTED
SpringWorks Therapeutics
SWTX
| $35.2M | ﹤0.01% |
1,340,630
+1,067,203
| +390% | +$28M |
|
805
Aaon
AAON
$7.23B
| $35.1M | ﹤0.01% |
555,939
+38,527
| +7% | +$2.44M |
|
|
LTHM
806
DELISTED
Livent Corporation
LTHM
| $35.1M | ﹤0.01% |
1,280,350
-101,045
| -7% | -$2.42M |
|
807
Kulicke & Soffa
KLIC
$5.01B
| $34.9M | ﹤0.01% |
587,603
-942
| -0.2% | -$48.6K |
|
808
Coty
COTY
$2.42B
| $34.8M | ﹤0.01% |
2,828,781
-323,024
| -10% | -$3.81M |
|
809
First Industrial Realty Trust
FR
$8.4B
| $34.7M | ﹤0.01% |
659,999
+16,099
| +3% | +$840K |
|
810
Willis Towers Watson
WTW
$31B
| $34.5M | ﹤0.01% |
146,372
-957
| -0.6% | -$221K |
|
|
HZNP
811
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $34.4M | ﹤0.01% |
334,676
-145,327
| -30% | -$15.3M |
|
812
M&T Bank
MTB
$36.6B
| $34.3M | ﹤0.01% |
277,121
-89,906
| -24% | -$10.9M |
|
813
Frontier Group Holdings
ULCC
$1.57B
| $34.3M | ﹤0.01% |
3,545,262
+78,984
| +2% | +$709K |
|
814
Prime Medicine
PRME
$575M
| $34.2M | ﹤0.01% |
2,333,831
+1,430,090
| +158% | +$20M |
|
815
Olin
OLN
$2.17B
| $33.8M | ﹤0.01% |
657,382
+284,176
| +76% | +$15.1M |
|
|
ACLX
816
DELISTED
Arcellx
ACLX
| $33.4M | ﹤0.01% |
1,057,781
+1,035,556
| +4,659% | +$39.6M |
|
817
Eversource Energy
ES
$27.2B
| $33.3M | ﹤0.01% |
470,195
-14,971
| -3% | -$1.11M |
|
818
CBRE Group
CBRE
$44B
| $33.2M | ﹤0.01% |
411,123
-7,874
| -2% | -$590K |
|
|
DISH
819
DELISTED
DISH Network Corp.
DISH
| $32.8M | ﹤0.01% |
4,977,153
-280,330
| -5% | -$1.99M |
|
820
T. Rowe Price
TROW
$23.7B
| $32.6M | ﹤0.01% |
291,120
-1,025
| -0.4% | -$112K |
|
821
Hilton Grand Vacations
HGV
$3.49B
| $32.4M | ﹤0.01% |
712,959
-37,112
| -5% | -$1.66M |
|
822
Cavco Industries
CVCO
$4.67B
| $32.3M | ﹤0.01% |
109,577
+4,318
| +4% | +$1.24M |
|
823
Tenable Holdings
TENB
$4.41B
| $32.3M | ﹤0.01% |
741,034
+27,116
| +4% | +$1.11M |
|
824
eBay
EBAY
$46.5B
| $32.2M | ﹤0.01% |
720,323
-12,578
| -2% | -$558K |
|
825
SM Energy
SM
$7.71B
| $32.1M | ﹤0.01% |
1,016,262
-103,590
| -9% | -$2.93M |
|
Similar funds
T. Rowe Price Associates's Q2 2023 Portfolio in Review
As of Q2 2023, T. Rowe Price Associates held 3,044 positions worth $718B, up 7.4% from $668B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q2 2023 filing shows 123 new, 1,636 increased, 968 reduced and 150 closed positions. Its largest new stake was Kenvue: 26,317,608 shares worth $695M. The largest sale was Microsoft, an estimated $1.92B.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2023 buy was Kenvue: 26,317,608 shares worth $695M.
- T. Rowe Price Associates added most to Amazon in Q2 2023, an estimated $3.11B increase.
- T. Rowe Price Associates's biggest Q2 2023 reduction was Microsoft, cutting an estimated $1.92B.
- T. Rowe Price Associates fully exited Canadian Natural Resources in Q2 2023, selling an estimated $112M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $718B portfolio in Q2 2023.
- T. Rowe Price Associates opened 123 new positions and closed 150 in Q2 2023.
- T. Rowe Price Associates's portfolio value rose 7.4% quarter-over-quarter to $718B.
Based on T. Rowe Price Associates's 13F filing for Q2 2023, filed 14 Aug 2023.